The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Targeting innate immunity protein kinase signalling in inflammation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling
Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,856
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Impaired On/Off Regulation of TNF Biosynthesis in Mice Lacking TNF AU-Rich Elements
Kontoyiannis, D., Pasparakis, M., Pizarro, T. T., Cominelli, F., & Kollias, G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80038-2 · Cited by 1,344
Intracellular pattern recognition receptors in the host response
Meylan, E., Tschopp, J., & Karin, M. (2006) · Nature · doi:10.1038/nature04946 · Cited by 1,206
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
TAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Essential function for the kinase TAK1 in innate and adaptive immune responses
Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1255 · Cited by 973
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., Griffiths, R. J., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 930
Historical insights into cytokines
Dinarello, C. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737772 · Cited by 926
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains
Kanayama, A., Seth, R. B., Sun, L., Ea, C.-K., Hong, M., Shaito, A., Chiu, Y.-H., Deng, L., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.008 · Cited by 888
Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4
Suzuki, N., Suzuki, S., Duncan, G. S., Millar, D. G., Wada, T., Mirtsos, C., Takada, H., Wakeham, A., Itie, A., Li, S., et al. (2002) · Nature · doi:10.1038/nature736 · Cited by 853
Active Caspase-1 Is a Regulator of Unconventional Protein Secretion
Keller, M., Rüegg, A., Werner, S., & Beer, H.-D. (2008) · Cell · doi:10.1016/j.cell.2007.12.040 · Cited by 850
TNF-α Induction by LPS Is Regulated Posttranscriptionally via a Tpl2/ERK-Dependent Pathway
Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J.-H., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00210-5 · Cited by 801
Han, Z., Boyle, D. L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A. M., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12466 · Cited by 780
MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D., & Gaestel, M. (1999) · Nature Cell Biology · doi:10.1038/10061 · Cited by 763
Self-citationTAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Shim, J.-H., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K.-Y., Bussey, C., Steckel, M., Tanaka, N., et al. (2005) · Genes & Development · doi:10.1101/gad.1360605 · Cited by 738
Inhibition of JNK activation through NF-κB target genes
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., & Lin, A. (2001) · Nature · doi:10.1038/35104568 · Cited by 721
The inflammasome: a danger sensing complex triggering innate immunity
Pétrilli, V., Dostert, C., Muruve, D. A., & Tschopp, J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.09.002 · Cited by 700
May, M. J., D'Acquisto, F., Madge, L. A., Glöckner, J., Pober, J. S., & Ghosh, S. (2000) · Science · doi:10.1126/science.289.5484.1550 · Cited by 680
A Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
A Mammalian Scaffold Complex That Selectively Mediates MAP Kinase Activation
Whitmarsh, A. J., Cavanagh, J., Tournier, C., Yasuda, J., & Davis, R. J. (1998) · Science · doi:10.1126/science.281.5383.1671 · Cited by 652 · cited 1×
“As with JIP1 overexpression or JIP-deletion mutant”
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005) · Nature · doi:10.1038/nature03491 · Cited by 626
Adalimumab with or without Methotrexate in Juvenile Rheumatoid Arthritis
Lovell, D. J., Ruperto, N., Goodman, S., Reiff, A., Jung, L., Jarosova, K., Nemcova, D., Mouy, R., Sandborg, C., Bohnsack, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706290 · Cited by 625
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Vallabhapurapu, S., Matsuzawa, A., Zhang, W., Tseng, P.-H., Keats, J. J., Wang, H., Vignali, D. A. A., Bergsagel, P. L., & Karin, M. (2008) · Nature Immunology · doi:10.1038/ni.1678 · Cited by 608
Reinhardt, H. C., Aslanian, A. S., Lees, J. A., & Yaffe, M. B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.024 · Cited by 596
Peyrin–Biroulet, L., Deltenre, P., de Suray, N., Branche, J., Sandborn, W. J., & Colombel, J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.014 · Cited by 577
Cell-Permeable Peptide Inhibitors of JNK
Bonny, C., Oberson, A., Negri, S., Sauser, C., & Schorderet, D. F. (2001) · Diabetes · doi:10.2337/diabetes.50.1.77 · Cited by 571
Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice
Tanaka, M., Fuentes, M. E., Yamaguchi, K., Durnin, M. H., Dalrymple, S. A., Hardy, K. L., & Goeddel, D. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80042-4 · Cited by 569
Ubiquitin Chain Editing Revealed by Polyubiquitin Linkage-Specific Antibodies
Newton, K., Matsumoto, M. L., Wertz, I. E., Kirkpatrick, D. S., Lill, J. R., Tan, J., Dugger, D., Gordon, N., Sidhu, S. S., Fellouse, F. A., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.039 · Cited by 555
The Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1β by Keratinocytes
Feldmeyer, L., Keller, M., Niklaus, G., Hohl, D., Werner, S., & Beer, H.-D. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.074 · Cited by 544
MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α
Ge, B., Gram, H., Di Padova, F., Huang, B., New, L., Ulevitch, R. J., Luo, Y., & Han, J. (2002) · Science · doi:10.1126/science.1067289 · Cited by 534
Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase
Bulavin, D. V., Higashimoto, Y., Popoff, I. J., Gaarde, W. A., Basrur, V., Potapova, O., Appella, E., & Fornace, A. J. (2001) · Nature · doi:10.1038/35075107 · Cited by 532
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., & Nebreda, A. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00014-6 · Cited by 516
Jimi, E., Aoki, K., Saito, H., D'Acquisto, F., May, M. J., Nakamura, I., Sudo, T., Kojima, T., Okamoto, F., Fukushima, H., et al. (2004) · Nature Medicine · doi:10.1038/nm1054 · Cited by 501
Mechanism of p38 MAP kinase activation in vivo
Brancho, D., Tanaka, N., Jaeschke, A., Ventura, J.-J., Kelkar, N., Tanaka, Y., Kyuuma, M., Takeshita, T., Flavell, R. A., & Davis, R. J. (2003) · Genes & Development · doi:10.1101/gad.1107303 · Cited by 490
Cao, Y., Bonizzi, G., Seagroves, T. N., Greten, F. R., Johnson, R., Schmidt, E. V., & Karin, M. (2001) · Cell · doi:10.1016/s0092-8674(01)00599-2 · Cited by 482
Combinatorial roles of nuclear receptors in inflammation and immunity
Glass, C. K., & Ogawa, S. (2006) · Nature Reviews Immunology · doi:10.1038/nri1748 · Cited by 464
Role of p38 and JNK Mitogen-Activated Protein Kinases in the Activation of Ternary Complex Factors
Whitmarsh, A. J., Yang, S.-H., Su, M. S.-S., Sharrocks, A. D., & Davis, R. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2360 · Cited by 455
Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2
Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T., Kawai, T., Takeuchi, O., & Akira, S. (2008) · Nature Immunology · doi:10.1038/ni.1606 · Cited by 442
Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060336 · Cited by 430 · cited 1×
“They induce transcriptional expression of MKP1 (a MAPK-specific phosphatase”
BackgroundYarilina, A., Park-Min, K.-H., Antoniv, T., Hu, X., & Ivashkiv, L. B. (2008) · Nature Immunology · doi:10.1038/ni1576 · Cited by 429
Manke, I. A., Nguyen, A., Lim, D., Stewart, M. Q., Elia, A. E. H., & Yaffe, M. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.021 · Cited by 416
MAPKAP kinases — MKs — two's company, three's a crowd
Gaestel, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1834 · Cited by 413
Self-citationNinomiya-Tsuji, J., Kajino, T., Ono, K., Ohtomo, T., Matsumoto, M., Shiina, M., Mihara, M., Tsuchiya, M., & Matsumoto, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207453200 · Cited by 409
PI3Kδ and PI3Kγ: partners in crime in inflammation in rheumatoid arthritis and beyond?
Rommel, C., Camps, M., & Ji, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2036 · Cited by 398
Neininger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H.-D., Holtmann, H., Kollias, G., & Gaestel, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100685200 · Cited by 393
Self-citationPost-transcriptional control of cytokine production
Anderson, P. (2008) · Nature Immunology · doi:10.1038/ni1584 · Cited by 376
Dennehy, K. M., Ferwerda, G., Faro‐Trindade, I., Pyż, E., Willment, J. A., Taylor, P. R., Kerrigan, A., Tsoni, S. V., Gordon, S., Meyer‐Wentrup, F., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737741 · Cited by 373
Buss, H., Dörrie, A., Schmitz, M. L., Hoffmann, E., Resch, K., & Kracht, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409825200 · Cited by 364
Self-citationCentral role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
Karaghiosoff, M., Steinborn, R., Kovarik, P., Kriegshäuser, G., Baccarini, M., Donabauer, B., Reichart, U., Kolbe, T., Bogdan, C., Leanderson, T., et al. (2003) · Nature Immunology · doi:10.1038/ni910 · Cited by 361
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
Hui, L., Bakiri, L., Mairhorfer, A., Schweifer, N., Haslinger, C., Kenner, L., Komnenovic, V., Scheuch, H., Beug, H., & Wagner, E. F. (2007) · Nature Genetics · doi:10.1038/ng2033 · Cited by 352
A comprehensive map of the toll‐like receptor signaling network
Oda, K., & Kitano, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100057 · Cited by 352
Weinblatt, M. E., Kavanaugh, A., Burgos‐Vargas, R., Dikranian, A. H., Medrano‐Ramirez, G., Morales‐Torres, J. L., Murphy, F. T., Musser, T. K., Straniero, N., Vicente‐Gonzales, A. V., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23992 · Cited by 342
Nicholas, C., Batra, S., Vargo, M. A., Voss, O. H., Gavrilin, M. A., Wewers, M. D., Guttridge, D. C., Grotewold, E., & Doseff, A. I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7121 · Cited by 339
Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide
Kaneto, H., Nakatani, Y., Miyatsuka, T., Kawamori, D., Matsuoka, T.-A., Matsuhisa, M., Kajimoto, Y., Ichijo, H., Yamasaki, Y., & Hori, M. (2004) · Nature Medicine · doi:10.1038/nm1111 · Cited by 337
O'Neill, L. A. J. (2008) · Immunity · doi:10.1016/j.immuni.2008.06.004 · Cited by 330
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
Ananieva, O., Darragh, J., Johansen, C., Carr, J. M., McIlrath, J., Park, J. M., Wingate, A., Monk, C. E., Toth, R., Santos, S. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1644 · Cited by 326
Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2
Papa, S., Zazzeroni, F., Bubici, C., Jayawardena, S., Alvarez, K., Matsuda, S., Nguyen, D. U., Pham, C. G., Nelsbach, A. H., Melis, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1093 · Cited by 321
Molecular recognitions in the MAP kinase cascades
Tanoue, T., & Nishida, E. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00112-2 · Cited by 318
Limiting inflammatory responses during activation of innate immunity
Han, J., & Ulevitch, R. J. (2005) · Nature Immunology · doi:10.1038/ni1274 · Cited by 315
The mouse kinome: Discovery and comparative genomics of all mouse protein kinases
Caenepeel, S., Charydczak, G., Sudarsanam, S., Hunter, T., & Manning, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306880101 · Cited by 308
Pirvola, U., Xing-Qun, L., Virkkala, J., Saarma, M., Murakata, C., Camoratto, A. M., Walton, K. M., & Ylikoski, J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00043.2000 · Cited by 307
Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases
Salvador, J. M., Mittelstadt, P. R., Guszczynski, T., Copeland, T. D., Yamaguchi, H., Appella, E., Fornace, A. J., & Ashwell, J. D. (2005) · Nature Immunology · doi:10.1038/ni1177 · Cited by 306
p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Ventura, J. J., Tenbaum, S., Perdiguero, E., Huth, M., Guerra, C., Barbacid, M., Pasparakis, M., & Nebreda, A. R. (2007) · Nature Genetics · doi:10.1038/ng2037 · Cited by 304
Podolin, P. L., Callahan, J. F., Bolognese, B. J., Li, Y. H., Carlson, K., Davis, T. G., Mellor, G. W., Evans, C., & Roshak, A. K. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074484 · Cited by 298
p38 MAP Kinase's Emerging Role as a Tumor Suppressor
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)92005-2 · Cited by 290
Frevel, M. A. E., Bakheet, T., Silva, A. M., Hissong, J. G., Khabar, K. S. A., & Williams, B. R. G. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.425-436.2003 · Cited by 288
Feedback control of the protein kinase TAK1 by SAPK2a/p38
Cheung, P. C. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg552 · Cited by 278
Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125
Heo, Y., Kim, S., Seo, C. I., Kim, Y. K., Sung, B., Lee, H. S., Lee, J. I., Park, S., Kim, J. H., Hwang, K. Y., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600212 · Cited by 275 · cited 1×
“Interestingly, the JIP1 peptide distorts the ATP binding site of JNK, which suggests that binding of scaffolds, activators or substrates to JNK is an additional determinant of the affinity of ATP-competitive inhibitors such as SP60012”
BackgroundA critical role for IRAK4 kinase activity in Toll-like receptor–mediated innate immunity
Kim, T. W., Staschke, K., Bulek, K., Yao, J., Peters, K., Oh, K.-H., Vandenburg, Y., Xiao, H., Qian, W., Hamilton, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061825 · Cited by 272
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3
Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z.-G., & Su, B. (2004) · Nature Immunology · doi:10.1038/ni1014 · Cited by 266
Lucet, I. S., Fantino, E., Styles, M., Bamert, R., Patel, O., Broughton, S. E., Walter, M., Burns, C. J., Treutlein, H., Wilks, A. F., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2413 · Cited by 266
Kim, C., Sano, Y., Todorova, K., Carlson, B. A., Arpa, L., Celada, A., Lawrence, T., Otsu, K., Brissette, J. L., Arthur, J. S. C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1640 · Cited by 265
Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)
Anderson, D. R., Hegde, S., Reinhard, E., Gomez, L., Vernier, W. F., Lee, L., Liu, S., Sambandam, A., Snider, P. A., & Masih, L. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.067 · Cited by 265
Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L.-C., Cao, Y., Schett, G., Wagner, E. F., & Karin, M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042081 · Cited by 252
Perdiguero, E., Ruiz‐Bonilla, V., Gresh, L., Hui, L., Ballestar, E., Sousa‐Victor, P., Baeza‐Raja, B., Jardí, M., Bosch‐Comas, A., Esteller, M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601587 · Cited by 251
Interactions of NF-κB with chromatin: the art of being at the right place at the right time
Natoli, G., Saccani, S., Bosisio, D., & Marazzi, I. (2005) · Nature Immunology · doi:10.1038/ni1196 · Cited by 250
Mekk3 is essential for early embryonic cardiovascular development
Yang, J., Boerm, M., McCarty, M., Bucana, C., Fidler, I. J., Z J Yang, Y., & Su, B. (2000) · Nature Genetics · doi:10.1038/73550 · Cited by 244
Collart, M. A., Baeuerle, P., & Vassalli, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1498-1506.1990 · Cited by 235
Distinct Cellular Functions of MK2
Kotlyarov, A., Yannoni, Y., Fritz, S., Laaß, K., Telliez, J.-B., Pitman, D., Lin, L.-L., & Gaestel, M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4827-4835.2002 · Cited by 230
Self-citationDrug-Induced Lupus due to Anti-Tumor Necrosis Factor α Agents
Costa, M. F., Said, N. R., & Zimmermann, B. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2007.08.003 · Cited by 227
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis
Paniagua, R. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28546 · Cited by 220
McIntyre, K. W., Shuster, D. J., Gillooly, K. M., Dambach, D. M., Pattoli, M. A., Lu, P., Zhou, X., Qiu, Y., Zusi, F. C., & Burke, J. R. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11131 · Cited by 217
Ronkina, N., Kotlyarov, A., Dittrich-Breiholz, O., Kracht, M., Hitti, E., Milarski, K., Askew, R., Marusic, S., Lin, L.-L., Gaestel, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01456-06 · Cited by 216
Self-citationBuxadé, M., Parra, J. L., Rousseau, S., Shpiro, N., Marquez, R., Morrice, N., Bain, J., Espel, E., & Proud, C. G. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.009 · Cited by 211
Pine, P. R., Chang, B., Schoettler, N., Banquerigo, M. L., Wang, S., Lau, A., Zhao, F., Grossbard, E. B., Payan, D. G., & Brahn, E. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.543 · Cited by 208
Waterfield, M. R., Zhang, M., Norman, L. P., & Sun, S.-C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00070-4 · Cited by 208
Rhoades, K. L., Golub, S. H., & Economou, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41641-9 · Cited by 207
An antiinflammatory role for IKKβ through the inhibition of “classical” macrophage activation
Fong, C. H. Y., Bebien, M., Didierlaurent, A., Nebauer, R., Hussell, T., Broide, D., Karin, M., & Lawrence, T. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080124 · Cited by 197
Dai, S., Hirayama, T., Abbas, S., & Abu-Amer, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400258200 · Cited by 196
Kanakaraj, P., Schafer, P. H., Cavender, D. E., Wu, Y., Ngo, K., Grealish, P. F., Wadsworth, S. A., Peterson, P. A., Siekierka, J. J., Harris, C. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2073 · Cited by 192
Identification of a new JNK inhibitor targeting the JNK-JIP interaction site
Stebbins, J. L., De, S. K., Machleidt, T., Becattini, B., Vazquez, J., Kuntzen, C., Chen, L.-H., Cellitti, J. F., Riel-Mehan, M., Emdadi, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805677105 · Cited by 186
The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes
Waeber, G., Delplanque, J., Bonny, C., Mooser, V., Steinmann, M., Widmann, C., Maillard, A., Miklossy, J., Dina, C., H Hani, E., et al. (2000) · Nature Genetics · doi:10.1038/73523 · Cited by 183
Varjosalo, M., Björklund, M., Cheng, F., Syvänen, H., Kivioja, T., Kilpinen, S., Sun, Z., Kallioniemi, O., Stunnenberg, H. G., He, W.-W., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.047 · Cited by 183
Endotoxin Tolerance Disrupts Chromatin Remodeling and NF-κB Transactivation at the IL-1β Promoter
Chan, C., Li, L., McCall, C. E., & Yoza, B. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.461 · Cited by 180
Crosstalk via the NF-κB signaling system
Basak, S., & Hoffmann, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.04.005 · Cited by 177
She, Q., Chen, N., Bode, A. M., Flavell, R. A., & Dong, Z. (2002) · PubMed · Cited by 173
Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)
Anderson, D. R., Meyers, M. J., Vernier, W. F., Mahoney, M. W., Kurumbail, R. G., Caspers, N., Poda, G. I., Schindler, J. F., Reitz, D. B., & Mourey, R. J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0611004 · Cited by 170
Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H., & Gaestel, M. (1999) · Cited by 167
Self-citationOpposing functions of IKKβ during acute and chronic intestinal inflammation
Eckmann, L., Nebelsiek, T., Fingerle, A. A., Dann, S. M., Mages, J., Lang, R., Robine, S., Kagnoff, M. F., Schmid, R. M., Karin, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808216105 · Cited by 165
p38 MAP kinase inhibitors: many are made, but few are chosen.
Dominguez, C., Powers, D. A., & Tamayo, N. A. (2005) · PubMed · Cited by 163
Macrophage Deletion of p38α Partially Impairs Lipopolysaccharide-Induced Cellular Activation
Kang, Y. J., Chen, J., Otsuka, M., Mols, J., Ren, S. V., Wang, Y., & Han, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5075 · Cited by 156
Takekawa, M., Tatebayashi, K., & Saito, H. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.001 · Cited by 155
Kajino‐Sakamoto, R., Inagaki, M., Lippert, E., Akira, S., Robine, S., Matsumoto, K., Jobin, C., & Ninomiya‐Tsuji, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1143 · Cited by 153
Wang, Z., Liu, J., Sudom, A. M., Ayres, M., Li, S., Wesche, H., Powers, J. P., & Walker, N. P. C. (2006) · Structure · doi:10.1016/j.str.2006.11.001 · Cited by 149
MAPKAP Kinase 2-Deficient Mice Are Resistant to Collagen-Induced Arthritis
Hegen, M., Gaestel, M., Nickerson-Nutter, C., Lin, L., & Telliez, J. (2006) · Journal of Immunology · doi:10.4049/jimmunol.177.3.1913 · Cited by 148
Self-citationBroide, D. H., Lawrence, T., Doherty, T. A., Cho, J. Y., Miller, M., McElwain, K., McElwain, S., & Karin, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509235102 · Cited by 148
Phosphorylation of SNAP-23 by IκB Kinase 2 Regulates Mast Cell Degranulation
Suzuki, K., & Verma, I. M. (2008) · Cell · doi:10.1016/j.cell.2008.05.050 · Cited by 148
Horwood, N. J., Mahon, T., McDaid, J., Campbell, J., Mano, H., Brennan, F. M., Webster, D., & Foxwell, B. M. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021845 · Cited by 145
Autoinflammatory Diseases: Clinical and Genetic Advances
Farasat, S., Aksentijevich, I. A., & Toro, J. R. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.3.392 · Cited by 143
Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis
Milici, A. J., Kudlacz, E. M., Audoly, L., Zwillich, S. H., & Changelian, P. S. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2365 · Cited by 142
Brimhall, A. K., King, L. N., Licciardone, J. C., Jacobe, H. T., & Menter, A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08673.x · Cited by 141
Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3
Liu, S., Sun, J.-P., Zhou, B., & Zhang, Z.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510506103 · Cited by 140
Doyle, S., Jefferies, C. A., & O'Neill, L. A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500053200 · Cited by 138
Rousseau, S., Papoutsopoulou, M., Symons, A., Cook, D., Lucocq, J. M., Prescott, A. R., O’Garra, A., Ley, S. C., & Cohen, P. (2008) · Journal of Cell Science · doi:10.1242/jcs.018671 · Cited by 134
Windheim, M., Stafford, M. J., Peggie, M. W., & Cohen, P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02380-06 · Cited by 134
Glucocorticoid receptor–JNK interaction mediates inhibition of the JNK pathway by glucocorticoids
Bruna, A., Nicolàs, M., Muñoz, A., Kyriakis, J. M., & Caelles, C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg590 · Cited by 130
Alford, K. A., Glennie, S. J., Turrell, B. R., Rawlinson, L. M., Saklatvala, J., & Dean, J. L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610987200 · Cited by 123
TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice
Tang, M., Wei, X., Guo, Y., Breslin, P., Zhang, S., Zhang, S., Wei, W., Xia, Z., Dı́az, M. O., Akira, S., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080297 · Cited by 121
Mader, M. M., de Dios, A., Shih, C., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.106 · Cited by 116
Han, Z., Chang, L., Yamanishi, Y., Karin, M., & Firestein, G. S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10104 · Cited by 116
Muniyappa, H., & Das, K. C. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.003 · Cited by 116
Spatially Separate Docking Sites on ERK2 Regulate Distinct Signaling Events In Vivo
Dimitri, C. A., Dowdle, W., MacKeigan, J. P., Blenis, J., & Murphy, L. O. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.037 · Cited by 114
Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation
Lin, T.-A., McIntyre, K. W., Das, J., Liu, C., O'Day, K., Penhallow, B. A., Hung, C.-Y., Whitney, G. S., Shuster, D. J., Yang, X.-X., et al. (2004) · Biochemistry · doi:10.1021/bi049428r · Cited by 113
Inoue, T., Boyle, D. L., Corr, M., Hammaker, D. R., Davis, R. J., Flavell, R. A., & Firestein, G. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509188103 · Cited by 109
Juurikivi, A., Sandler, C., Lindstedt, K. A., Kovanen, P. T., Juutilainen, T., Leskinen, M. J., Mäki, T., & Eklund, K. K. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029835 · Cited by 103
Heinrichsdorff, J., Luedde, T., Perdiguero, E., Nebreda, Á. R., & Pasparakis, M. (2008) · EMBO Reports · doi:10.1038/embor.2008.149 · Cited by 102
Thiel, M., Schaefer, C. J., Lesch, M. E., Mobley, J. L., Dudley, D. T., Tecle, H., Barrett, S. D., Schrier, D. J., & Flory, C. M. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22869 · Cited by 101
Omori, E., Morioka, S., Matsumoto, K., & Ninomiya‐Tsuji, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804513200 · Cited by 101
A new p38 MAP kinase‐regulated transcriptional coactivator that stimulates p53‐dependent apoptosis
Cuadrado, A., Lafarga, V., Cheung, P., Dolado, I., Llanos, S., Cohen, P., & Nebreda, Á. R. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601657 · Cited by 101
Posttranslational modifications of NEMO and its partners in NF-κB signaling
Sebban, H., Yamaoka, S., & Courtois, G. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.09.004 · Cited by 99
Cytokine-Induced Signaling Networks Prioritize Dynamic Range over Signal Strength
Janes, K. A., Reinhardt, H. C., & Yaffe, M. B. (2008) · Cell · doi:10.1016/j.cell.2008.08.034 · Cited by 99
Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF‐κB inhibition
Beck, I. M. E., Berghe, W. V., Vermeulen, L., Bougarne, N., Cruyssen, B. V., Haegeman, G., & Bosscher, K. D. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.95 · Cited by 98
c-Jun NH2-Terminal Kinase 1 Is a Critical Regulator for the Development of Gastric Cancer in Mice
Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Sakamoto, K., Nakagawa, H., Ogura, K., Karin, M., & Omata, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6332 · Cited by 97
Gorska, M. M., Liang, Q., Stafford, S. J., Goplen, N., Dharajiya, N. G., Guo, L., Sur, S. A., Gaestel, M., & Alam, R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062621 · Cited by 97
Self-citationUV as an Amplifier Rather Than Inducer of NF-κB Activity
O'Dea, E. L., Kearns, J. D., & Hoffmann, A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.017 · Cited by 96
Komatsu, Y., Shibuyà, H., Takeda, N., Ninomiya‐Tsuji, J., Yasui, T., Miyado, K., Sekimoto, T., Ueno, N., Matsumoto, K., & Yamada, G. (2002) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00391-x · Cited by 96
Protein Kinases as Small Molecule Inhibitor Targets in Inflammation
Gaestel, M., Mengel, A., Bothe, U., & Asadullah, K. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781696636 · Cited by 96
Self-citationMedicherla, S., Fitzgerald, M. F., Spicer, D., Woodman, P., Ma, J. Y., Kapoun, A. M., Chakravarty, S., Dugar, S., Protter, A. A., & Higgins, L. S. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.127092 · Cited by 94
Nixon, R. M., Bansback, N. J., & Brennan, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem072 · Cited by 94
Potential Adverse Effects Associated with Inhibition of p38α/β MAP Kinases
Dambach, D. M. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054985911 · Cited by 93
c-Jun NH2-Terminal Kinase 1 Plays a Critical Role in Intestinal Homeostasis and Tumor Suppression
Tong, C., Yin, Z., Song, Z., Dockendorff, A., Huang, C., Mariadason, J. M., Flavell, R. A., Davis, R. J., Augenlicht, L. H., & Yang, W. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061036 · Cited by 93
Multiple effects of acetaminophen and p38 inhibitors: Towards pathway toxicology
Xu, J. J., Hendriks, B. S., Zhao, J., & de Graaf, D. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.063 · Cited by 87
Wolter, S., Doerrie, A., Weber, A., Schneider, H., Hoffmann, E., von der Ohe, J., Bakiri, L., Wagner, E. F., Resch, K., & Kracht, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00535-07 · Cited by 86
Self-citationRole of a cysteine residue in the active site of ERK and the MAPKK family
Ohori, M., Kinoshita, T., Yoshimura, S., Warizaya, M., Nakajima, H., & Miyake, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.083 · Cited by 85
Medicherla, S., Jing, Y., Mangadu, R., Jiang, Y., Zhao, J. J., Almirez, R. G., Kerr, I., Stebbins, E. G., O’Young, G., Kapoun, A. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098020 · Cited by 83
Use of cell permeable NBD peptides for suppression of inflammation
Strickland, I., & Ghosh, S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058438 · Cited by 83
McCoy, C. E., Carpenter, S., Pålsson-McDermott, E. M., Gearing, L. J., & O'Neill, L. A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709731200 · Cited by 82 · cited 1×
“and inhibit TLR3- and TLR4-dependent TANK-binding kinase 1 (TBK1) activation and interferon regulatory factor 3 (IRF3) phosphorylatio”
BackgroundHall, J. P., Kurdi, Y., Hsu, S., Cuozzo, J. W., Liu, J. X., Telliez, J., Seidl, K. J., Winkler, A. R., Hu, Y., Green, N., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703694200 · Cited by 82
Lehner, M. D., Schwoebel, F., Kotlyarov, A., Leist, M., Gaestel, M., & Härtung, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4667 · Cited by 80
Self-citationPascual, V., Allantaz, F., Patel, P., Palucka, K., Chaussabel, D., & Banchereau, J. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00643.x · Cited by 78
Negative Feedback Regulation of MKK6 mRNA Stability by p38α Mitogen-Activated Protein Kinase
Ambrosino, C., Macé‐Aimé, G., Galbán, S., Fritsch, C., Vintersten, K., Black, E. V. I., Gorospe, M., & Nebreda, Á. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.370-381.2003 · Cited by 78
Tas, S. W., Vervoordeldonk, M. J., Hajji, N., May, M. J., Ghosh, S., & Tak, P. P. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1958 · Cited by 77
Mendoza, H., Campbell, D. G., Burness, K. A., Hastie, C. J., Ronkina, N., Shim, J., Arthur, J. S. C., Davis, R. J., Gaestel, M., Johnson, G. L., et al. (2008) · Biochemical Journal · doi:10.1042/bj20071149 · Cited by 68
Self-citationJNK1 Is Required for T Cell-Mediated Immunity Against Leishmania major Infection
Constant, S. L., Dong, C., Yang, D. D., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2671 · Cited by 66
Ohori, M., Takeuchi, M., Maruki, R., Nakajima, H., & Miyake, H. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0117-7 · Cited by 64
Martin, M. W., Newcomb, J. R., Nunes, J. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701095m · Cited by 64
Jak3 negatively regulates dendritic-cell cytokine production and survival
Yamaoka, K., Min, B., Zhou, Y.-J., Paul, W. E., & O’Shea, J. J. (2005) · Blood · doi:10.1182/blood-2005-02-0769 · Cited by 62
Stojanović, I., Cuzzocrea, S., Mangano, K., Mazzon, E., Miljković, D. M., Wang, M., Donia, M., Abed, Y. A., Kim, J., Nicoletti, F., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.03.004 · Cited by 60
The discovery of carboline analogs as potent MAPKAP-K2 inhibitors
Wu, J., Wang, J., Abeywardane, A., Andersen, D. L., Emmanuel, M. J., Gautschi, E., Goldberg, D. R., Kashem, M. A., Lukas, S., Wang, M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.101 · Cited by 59
Ding, C. (2006) · PubMed · Cited by 58
Dynamic Protein Associations Define Two Phases of IL-1β Transcriptional Activation
Zhang, Y., Saccani, S., Shin, H., & Nikolajczyk, B. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.503 · Cited by 57
The Interleukin-1β Gene Is Transcribed from a Poised Promoter Architecture in Monocytes
Liang, M. D., Zhang, Y., McDevit, D. C., Marecki, S., & Nikolajczyk, B. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510700200 · Cited by 55
Mihara, K., Almansa, C., Smeets, R., Loomans, E., Dulos, J., Vink, P. M., Rooseboom, M., Kreutzer, H., Cavalcanti, F., Boots, A., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.53 · Cited by 51
The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors
Cheung, M., Harris, P. A., Badiang, J. G., Peckham, G. E., Chamberlain, S. D., Alberti, M. J., Jung, D. K., Harris, S. S., Bramson, H. N., Epperly, A. H., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.09.040 · Cited by 46
Green, N., Hu, Y., Janz, K., Li, H., Kaila, N., Guler, S. Y., Thomason, J. R., Joseph‐McCarthy, D., Tam, S. Y. K., Hotchandani, R., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070436q · Cited by 46
P2 purinergic receptor modulation of cytokine production
Gabel, C. A. (2007) · Purinergic Signalling · doi:10.1007/s11302-006-9034-y · Cited by 45
Negative regulation of SEK1 signaling by serum‐ and glucocorticoid‐inducible protein kinase 1
Kim, M., Chae, J. S., Kim, K. J., Hwang, S. G., Yoon, K. W., Kim, E., Yun, H. J., Cho, J., Kim, J., Kim, B., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601755 · Cited by 38
Sustained response to anakinra in ankylosing spondylitis
Bennett, A. N., Tan, A. L., Coates, L. C., Emery, P., Marzo‐Ortega, H., & McGonagle, D. (2007) · Rheumatology · doi:10.1093/rheumatology/kem302 · Cited by 33
Structural Basis for a High Affinity Inhibitor Bound to Protein Kinase MK2
Hillig, R. C., Eberspaecher, U., Monteclaro, F. S., Huber, M., Nguyen, D., Mengel, A., Müller‐Tiemann, B., & Egner, U. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.004 · Cited by 32
Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Gaestel, M., & Kracht, M. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682299 · Cited by 27
Self-citationPettus, L. H., Xu, S., Cao, G., Chakrabarti, P. P., Rzasa, R. M., Sham, K. K. C., Wurz, R. P., Zhang, D., Middleton, S., Henkle, B., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8005405 · Cited by 27
Discovery of thieno[2,3-c]pyridines as potent COT inhibitors
George, D. M., Friedman, M., Allen, H., Argiriadi, M. A., Barberis, C., Bischoff, A. K., Clabbers, A., Cusack, K. P., Dixon, R., Fix-Stenzel, S. R., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.037 · Cited by 26
Cited by
Weber, A., Wasiliew, P., & Kracht, M. (2010) · Science Signaling · doi:10.1126/scisignal.3105cm1 · Cited by 962
Self-citationTNF and MAP kinase signalling pathways
Sabio, G., & Davis, R. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.02.009 · Cited by 700
Diversity and versatility of p38 kinase signalling in health and disease
Canovas, B., & Nebreda, A. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00322-w · Cited by 657
The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Yong, H.-Y., Koh, M.-S., & Moon, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903321490 · Cited by 422
Silva Andrade, B., Siqueira, S., de Assis Soares, W. R., de Souza Rangel, F., Santos, N. O., dos Santos Freitas, A., Ribeiro da Silveira, P., Tiwari, S., Alzahrani, K. J., Góes-Neto, A., et al. (2021) · Viruses · doi:10.3390/v13040700 · Cited by 435
Metadata
- Authors
- Gaestel, M., Kotlyarov, A., & Kracht, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-06
- Volume
- 8
- Issue
- 6
- Pages
- 480-499
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1967965268
- Cited by
- 316
- References
- 185
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.